m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
/MF-Logo-img/73700.png

WhiteOak Capital Pharma and Healthcare Fund-Dir (G)

Sectoral / Thematic
  • NAV

    14.16(0.29%)
  • Fund Size (CR)

    ₹508.73
  • Expense Ratio

    0.66
  • Scheme Type

    Active Fund
  • Value Research

  • Min. investment

    ₹500
  • Minimum Additional Investment

    ₹500
  • Minimum SIP Investment

    ₹100
  • Minimum Withdrawal

    ₹500
  • Exit Load In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed / switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.

    1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment

    1%
  • Return Since Launch

    19.54%
  • 3M
  • 6M
  • 1Y
  • 3Y
  • All
Absolute Return: -2.07%
Annualized Return: 0% [object Object]
1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment

Basic Details

Scheme Manager

Ramesh Mantri

Bench Mark

BSE Healthcare TRI

Type

OPEN

Lumpsum Returns

Period Invested For₹10,000 Invested onLatest ValueAbsolute ReturnsAnnualised ReturnsCategory AvgRank within Category
1 Week 5 January 20269851.41-1.49%--2.34%173/964
1 Month12 December 20259824.00-1.76%--0.86%690/960
3 Month10 October 20259773.01-2.27%--0.25%643/920
6 Month11 July 202510134.921.35%-1.19%382/880
1 Year10 January 202510430.614.31%4.31%6.47%420/820
3 Year------/-
5 Year------/-
Since Inception6 February 202414122.0041.22%19.54%11.90%134/964

Note: Lumpsum Returns since Inception Date.

SIP Returns

Period Invested For₹10,000 Invested onInvestmentsLatest ValueAbsolute ReturnsAnnualised Returns
1 Year3 February 20251,20,000124722.083.94% 3.94%
3 Year-----
5 Year-----
10 Year-----

Note: SIP Returns since Inception Date.

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Mutual Funds Calculator

  • Investment type
  • Scheme based
  • SIP
  • Lumpsum

Monthly Investment (₹)

Minimum value allowed is 500

Expected Returns Rate (%)

Minimum value allowed is 1

Time Period (in Years)

Minimum value allowed is 1
  • Invested Amount

    25,000

  • Estimated Returns

    19,059

76%

Returns

Future value of your investment

44,059

Risk Ratios

4.77%

Standard Deviation

0.83%

Beta

0.84%

Sharpe Ratio

-0.01%

Treynor's Ratio

10.65%

Jension's Alpha

Asset Allocation

Sector Allocation

Top 10 stock holding in portfolio

Stock Invested in% of Total HoldingsQuantityValue (Cr)Asset TypeSegment
Sun Pharma.Inds.10.91%32285955.52EquityPharmaceuticals
J B Chemicals &8.38%23429142.63EquityPharmaceuticals
Max Healthcare6.90%33566835.08EquityHealthcare
Laurus Labs5.44%24963027.66EquityPharmaceuticals
Fortis Health.5.25%30196926.69EquityHealthcare
Lupin4.79%11547924.36EquityPharmaceuticals
Divi's Lab.4.50%3583822.91EquityPharmaceuticals
Cipla3.90%13119019.83EquityPharmaceuticals
Alkem Lab2.76%2554114.06EquityPharmaceuticals
Neuland Labs.2.49%834212.66EquityPharmaceuticals

Peer Comparison

Scheme NameValue ResearchAsset Size (Cr)1M3M6M1Y3Y
WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
508.73-1.76%-2.27%1.35%4.31%-
Nippon India Taiwan Equity Fund - Direct (G)
427.470.96%9.65%36.97%55.25%39.86%
Nippon India Taiwan Equity Fund - Direct (IDCW)
427.470.96%9.65%36.97%55.25%39.86%
Aditya Birla SL International Equity Fund - Direct (G)
275.882.57%4.32%15.95%38.54%17.15%
Aditya Birla SL International Equity Fund - Direct (IDCW)
275.882.57%4.32%15.95%38.54%17.15%
Franklin Asian Equity Fund - Direct (G)
314.583.94%7.73%20.57%32.39%12.94%

List of Schemes under WhiteOak Capital Mutual Fund

News

  • WhiteOak Capital Mutual Fund announces change in Key Personnel

    WhiteOak Capital Mutual Fund has that Mr. Avinash Sonker has been appointed as Head ' Information Technology (IT) of WhiteOak Capital Asset Management Limited effective January 01, 2026.

    Details of Mr. Avinash Sonker

    Age: 47 years

    Designation: Associate Director & Head IT

    Qualification: Computer Science Engineering

    Powered by Capital Market - Live News

  • WhiteOak Capital Mutual Fund Announces Resignation of Key Personnel

    WhiteOak Capital Mutual Fund has announced that, Mr. Vaiibhavv Chugh will cease to be the Head ' Sales of WhiteOak Capital Asset Management Limited w.e.f. the close of business hours of September 30, 2025.

    Powered by Capital Market - Live News

Fund House Details & Investment Objective

Date of Incorporation

16 January 2024

Total AUM (Cr)

₹508.73

WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, WhiteOak Capital Mutual Fund. Launched in 16 January 2024, this fund is managed by Ramesh Mantri. With assets under management (AUM) worth ₹508.73 (Cr), as of 13 January 2026, WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 19.54% since its launch.
The current NAV of WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is ₹14.16, as on 13 January 2026. The fund's benchmark index is BSE Healthcare TRI. You can invest in WhiteOak Capital Pharma and Healthcare Fund-Dir (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹500.

Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.

The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 93.65% in Equity, 6.37% in Debt and -0.02% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 58.06% in Pharmaceuticals & Biotech, 26.17% in Healthcare Services, 11.91% in Debt, 1.91% in Industrial Products, 1.25% in Healthcare Equipment & Su